186 related articles for article (PubMed ID: 23749691)
1. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
Sands D
Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691
[TBL] [Abstract][Full Text] [Related]
2. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
3. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796
[TBL] [Abstract][Full Text] [Related]
4. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
5. Basic protocol for transepithelial nasal potential difference measurements.
Schüler D; Sermet-Gaudelus I; Wilschanski M; Ballmann M; Dechaux M; Edelman A; Hug M; Leal T; Lebacq J; Lebecque P; Lenoir G; Stanke F; Wallemacq P; Tümmler B; Knowles MR
J Cyst Fibros; 2004 Aug; 3 Suppl 2():151-5. PubMed ID: 15463949
[TBL] [Abstract][Full Text] [Related]
6. Insights into the variability of nasal potential difference, a biomarker of CFTR activity.
Kyrilli S; Henry T; Wilschanski M; Fajac I; Davies JC; Jais JP; Sermet-Gaudelus I
J Cyst Fibros; 2020 Jul; 19(4):620-626. PubMed ID: 31699569
[TBL] [Abstract][Full Text] [Related]
7. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
Middleton PG; Geddes DM; Alton EW
Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
[TBL] [Abstract][Full Text] [Related]
8. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
Sermet-Gaudelus I; Girodon E; Sands D; Stremmler N; Vavrova V; Deneuville E; Reix P; Bui S; Huet F; Lebourgeois M; Munck A; Iron A; Skalicka V; Bienvenu T; Roussel D; Lenoir G; Bellon G; Sarles J; Macek M; Roussey M; Fajac I; Edelman A
Am J Respir Crit Care Med; 2010 Oct; 182(7):929-36. PubMed ID: 20538955
[TBL] [Abstract][Full Text] [Related]
9. Nasal potential difference in congenital bilateral absence of the vas deferens.
Pradal U; Castellani C; Delmarco A; Mastella G
Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023
[TBL] [Abstract][Full Text] [Related]
10. Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.
Tridello G; Menin L; Pintani E; Bergamini G; Assael BM; Melotti P
J Cyst Fibros; 2016 Sep; 15(5):579-82. PubMed ID: 27423539
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium.
Rückes-Nilges C; Lindemann H; Klimek T; Glanz H; Weber WM
Pflugers Arch; 2000 Nov; 441(1):133-7. PubMed ID: 11205052
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.
Mainz J; Hammer U; Rokahr C; Hubler A; Zintl F; Ballmann M
Respiration; 2006; 73(5):698-704. PubMed ID: 16763370
[TBL] [Abstract][Full Text] [Related]
13. A multiple reader scoring system for Nasal Potential Difference parameters.
Solomon GM; Liu B; Sermet-Gaudelus I; Fajac I; Wilschanski M; Vermeulen F; Rowe SM
J Cyst Fibros; 2017 Sep; 16(5):573-578. PubMed ID: 28465124
[TBL] [Abstract][Full Text] [Related]
14. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
[TBL] [Abstract][Full Text] [Related]
15. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
Mall M; Bleich M; Greger R; Schreiber R; Kunzelmann K
J Clin Invest; 1998 Jul; 102(1):15-21. PubMed ID: 9649552
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
Lubamba B; Lecourt H; Lebacq J; Lebecque P; De Jonge H; Wallemacq P; Leal T
Am J Respir Crit Care Med; 2008 Mar; 177(5):506-15. PubMed ID: 18006891
[TBL] [Abstract][Full Text] [Related]
17. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
Middleton PG; House HH
Pediatr Pulmonol; 2010 Aug; 45(8):789-95. PubMed ID: 20597077
[TBL] [Abstract][Full Text] [Related]
18. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
Sermet-Gaudelus I; Déchaux M; Vallée B; Fajac A; Girodon E; Nguyen-Khoa T; Marianovski R; Hurbain I; Bresson JL; Lenoir G; Edelman A
Am J Respir Crit Care Med; 2005 May; 171(9):1026-31. PubMed ID: 15709055
[TBL] [Abstract][Full Text] [Related]
19. Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.
Naehrlich L; Ballmann M; Davies J; Derichs N; Gonska T; Hjelte L; van Konigsbruggen-Rietschel S; Leal T; Melotti P; Middleton P; Tümmler B; Vermeulen F; Wilschanski M;
J Cyst Fibros; 2014 Jan; 13(1):24-8. PubMed ID: 24022019
[TBL] [Abstract][Full Text] [Related]
20. The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis.
Davies MG; Geddes DM; Alton EW
Am J Respir Crit Care Med; 2005 Apr; 171(7):760-3. PubMed ID: 15618459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
